Lupin Launches Formoterol Fumarate Inhalation Solution in th

Lupin Limited today announced the launch of Formoterol Fumarate Inhalation Solution, 20 mcg/2 mL per Unit-Dose Vial, to market a generic equivalent of Perforomist® Inhalation Solution, 20 mcg/2 mL, of Mylan Specialty, L.P.

Related Keywords

United States , , Lupin Limited , Formoterol Fumarate Inhalation Solution , Unit Dose Vial , Inhalation Solution , Mylan Specialty , Fumarate Inhalation Solution , Lupin , Ine326a01037 , Formoterolfumarateinhalationsolution , Perforomist , Mylanspecialty ,